Abstract
EDITORIAL WHAT ROLE FOR PROTEIN‐CONJUGATE PNEUMOCOCCAL VACCINE IN OLDER ADULTS? Invasive pneumococcal disease is a significant cause of morbidity and mortality among persons aged 65 years and older. Pneumococcal disease burden also remains high among adults over 50 years of age. In this editorial the authors discuss the priority of continued 23‐valent pneumococcal polysaccharide vaccine use in older adults, whilst
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
